Polycab India Q1 Review - Covid-19 Pinches In The Quarter: Dolat Capital
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Polycab India Ltd.'s Q1 saw sales, Ebitda and profit before tax coming in higher by 93%, 2.4 times and 2.5 times YoY at Rs 18.8 billion, Rs 1.4 billion and Rs 1 billion respectively due to the base effect of a weak quarter in Q1 FY21.
Overall Ebitda margins came in at 7.4%, with negative operating leverage in fast moving electrical goods.
Net cash position in Q1 was Rs 6.7 billion lower as compared to Q4 FY21 which was at Rs 9.1 billion, as working capital went up.
Polycab India has a multi-year growth strategy, where they target sales of Rs 200 billion by FY26.
This translates into ~18% compound annual growth rate over the next five years.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.